181 related articles for article (PubMed ID: 12127664)
1. Interferon beta treatment in relapsing-remitting multiple sclerosis. A review.
Grigoriadis N
Clin Neurol Neurosurg; 2002 Jul; 104(3):251-8. PubMed ID: 12127664
[No Abstract] [Full Text] [Related]
2. Long-term benefits of early and high doses of interferon beta-1a treatment in relapsing-remitting multiple sclerosis.
Chofflon M; Ben-Amor AF
Clin Neurol Neurosurg; 2002 Jul; 104(3):244-8. PubMed ID: 12127662
[No Abstract] [Full Text] [Related]
3. Treatment of multiple sclerosis with interferon beta 1b.
Dhib-Jalbut S; McFarland HF
Baillieres Clin Neurol; 1997 Oct; 6(3):467-80. PubMed ID: 10101584
[TBL] [Abstract][Full Text] [Related]
4. Multiple sclerosis and interferon beta-1b, past, present and future.
Horowski R
Clin Neurol Neurosurg; 2002 Jul; 104(3):259-64. PubMed ID: 12127665
[No Abstract] [Full Text] [Related]
5. Full results of the Evidence of Interferon Dose-Response-European North American Comparative Efficacy (EVIDENCE) study: a multicenter, randomized, assessor-blinded comparison of low-dose weekly versus high-dose, high-frequency interferon beta-1a for relapsing multiple sclerosis.
Schwid SR; Panitch HS
Clin Ther; 2007 Sep; 29(9):2031-48. PubMed ID: 18035202
[TBL] [Abstract][Full Text] [Related]
6. Interferon beta-1a in relapsing-remitting multiple sclerosis.
Blumhardt L
Hosp Med; 1999 Mar; 60(3):192-5. PubMed ID: 10476242
[TBL] [Abstract][Full Text] [Related]
7. Interferon beta-1b and childhood multiple sclerosis.
Adams AB; Tyor WR; Holden KR
Pediatr Neurol; 1999 Jul; 21(1):481-3. PubMed ID: 10428435
[TBL] [Abstract][Full Text] [Related]
8. Interferon-beta therapy in multiple sclerosis: evidence for a clinically relevant dose response.
Goodin DS
Drugs; 2001; 61(12):1693-703. PubMed ID: 11693459
[TBL] [Abstract][Full Text] [Related]
9. [High doses of interferon in the treatment of multiple sclerosis].
Muñoz D
Rev Neurol; 2001 May 1-15; 32(9):899. PubMed ID: 11424041
[No Abstract] [Full Text] [Related]
10. [Interferons and neurologic diseases].
Vermersch P; de Seze J; Ferriby D; Stojkovic T
Rev Med Interne; 2002 Nov; 23 Suppl 4():475s-480s. PubMed ID: 12481402
[TBL] [Abstract][Full Text] [Related]
11. The use of interferon beta in relapsing-remitting multiple sclerosis.
Etheridge LJ; Beverley DW; Ferrie C; McManus E
Arch Dis Child; 2004 Aug; 89(8):789-91. PubMed ID: 15269086
[TBL] [Abstract][Full Text] [Related]
12. Interferon beta 1a.
Pozzilli C; Koudriavtseva T
Baillieres Clin Neurol; 1997 Oct; 6(3):481-93. PubMed ID: 10101585
[TBL] [Abstract][Full Text] [Related]
13. [ALEMTUZUMAB: BENEFITS AND CHALLENGES OF A NEW THERAPY IN MULTIPLE SCLEROSIS].
Illés Z; Sejbaek T; Csépány T
Ideggyogy Sz; 2015 May; 68(5-6):155-64. PubMed ID: 26182606
[TBL] [Abstract][Full Text] [Related]
14. Interferon beta-1a and beta-1b for treatment of multiple sclerosis.
Benatar M
Lancet; 2002 Nov; 360(9343):1428; author reply 1428-9. PubMed ID: 12424021
[No Abstract] [Full Text] [Related]
15. Interferon, azathioprine and corticosteroids in multiple sclerosis: 6-year follow-up of the ASA cohort.
Kalincik T; Horakova D; Dolezal O; Krasensky J; Vaneckova M; Seidl Z; Havrdova E
Clin Neurol Neurosurg; 2012 Sep; 114(7):940-6. PubMed ID: 22402204
[TBL] [Abstract][Full Text] [Related]
16. [Interferon beta and copolymer-1: mechanism of action and clinical effects in multiple sclerosis].
Losy J
Neurol Neurochir Pol; 2000; 34(3 Suppl):63-9. PubMed ID: 10983302
[TBL] [Abstract][Full Text] [Related]
17. Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis (INCOMIN Trial) II: analysis of MRI responses to treatment and correlation with Nab.
Barbero P; Bergui M; Versino E; Ricci A; Zhong JJ; Ferrero B; Clerico M; Pipieri A; Verdun E; Giordano L; Durelli L;
Mult Scler; 2006 Feb; 12(1):72-6. PubMed ID: 16459722
[TBL] [Abstract][Full Text] [Related]
18. Newer long-term treatments for multiple sclerosis.
Pryse-Phillips W
Clin Neurol Neurosurg; 2002 Jul; 104(3):265-71. PubMed ID: 12127666
[No Abstract] [Full Text] [Related]
19. Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN).
Durelli L; Verdun E; Barbero P; Bergui M; Versino E; Ghezzi A; Montanari E; Zaffaroni M;
Lancet; 2002 Apr; 359(9316):1453-60. PubMed ID: 11988242
[TBL] [Abstract][Full Text] [Related]
20. [The role of interferon beta in the treatment of multiple sclerosis].
Seeldrayers P
Rev Med Brux; 1999 Sep; 20(4):A264-7. PubMed ID: 10523902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
